RecruitingPhase 1Phase 2NCT06345560
Pharmacokinetics of Drospirenone Only Pills: A Pre- and Post-Bariatric Surgery Study
Pharmacokinetics of Drospirenone Only Pills in Obese Thai Women: A Pre- and Post-Bariatric Surgery Study
Sponsor
Chulalongkorn University
Enrollment
16 participants
Start Date
Apr 18, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to investigate whether bariatric surgery affects Drospirenone only pills absorption
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years
Inclusion Criteria4
- Thai women aged 18-45 years who are obese and had an appointment for Bariatric surgery at Chulalongkorn Hospital
- Need contraception
- Able to use non-hormonal contraception during the study
- Giving consent
Exclusion Criteria8
- Pregnancy or history of giving birth within 3 months
- Breastfeeding within the 6 months
- History of using DMPA within 12 months
- History of using other types of hormonal birth control pills within 4 weeks
- History of bilateral oophorectomy or hysterectomy
- Suspected ovarian tumor or pathological ovarian cyst
- Regular cigarette smoking
- Contraindications to Drospirenone
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGDrospirenone
4 mg tablet once daily
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06345560
Related Trials
Drospirenone Only Pills and Cervical Mucus Changes: A Pre- and Post-Bariatric Surgery Study
NCT063455861 location
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
NCT059777518 locations
Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women With Substance Use Disorder in the Immediate Postpartum Period
NCT049390121 location
Investigating Ovulation Inhibition for Use as a Contraceptive
NCT073659041 location
Patient-centered Information on Permanent Contraception
NCT062967971 location